ロード中...
Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
BACKGROUND: We evaluated the efficacy and safety of acarbose add-on therapy in Korean patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled with metformin and sitagliptin. METHODS: A total of 165 subjects were randomized to metformin and sitagliptin (Met+Sita, n=65), metformi...
保存先:
| 出版年: | Diabetes Metab J |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Diabetes Association
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581543/ https://ncbi.nlm.nih.gov/pubmed/30604599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0054 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|